ZYNEX INC — Director's Dealing 2021

Apr 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZYNEX INC (ZYXI)
CIK: 0000846475
Period of Report: 2021-04-14

Reporting Person: Papandrea Giuseppe (COO - Zynex Medical, Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-14	Common Stock	M	24093	—	Acquired	30828	Direct
2021-04-14	Common Stock	M	666	—	Acquired	31494	Direct
2021-04-14	Common Stock	F	438	—	Disposed	31056	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-14	Options to Purchase Common Stock	$7.87	M	50000	Disposed	2029-07-22	Common Stock (24093)	Direct
2021-04-14	Options to Purchase Common Stock	$8.96	M	1625	Disposed	2029-12-12	Common Stock (666)	Direct

Footnotes

F1: Reflects the exercise of 50,000 vested options at an exercise price of $7.87 per share less the number of shares to fund the cashless exercise of such options at the market price of $15.19 per share.

F2: Reflects the exercise of 1,625 vested options at an exercise price of $8.96 per share less the number of shares to fund the cashless exercise of such options at the market price of $15.19 per share.

F3: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the shares underlying the exercised options. There was no sale involved in this cashless transaction.